Data as of Dec 18
| +0.0349 / +11.63%|
The 1 analysts offering 12-month price forecasts for BG Medicine Inc have a median target of 1.40, with a high estimate of 1.40 and a low estimate of 1.40. The median estimate represents a +318.04% increase from the last price of 0.33.
The current consensus among 1 polled investment analysts is to Hold stock in BG Medicine Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.